Eh, I think we are all a bit confused by the seeming inconsistency in the prospectus.
One portion looks to be from MD&A and suggests 200 patients completed by Q2-2021. But then for the 'Proceeds of the Offering' section, we see a bit about 210 by end of Q1-2021 and 400 by Q2-2021.
Now... the question is are we being consistent about dates and reference to calendar/fiscal year? We all believed the primary dosage on the 210 was complete or would be compete by end of December seeing as we were 'on pace' (MFs words in Dec 23 release).
Inconsistencies in interpretation are what is causing this hubbub.